Ventas (VTR) Upgraded to “Buy” by ValuEngine

ValuEngine upgraded shares of Ventas (NYSE:VTR) from a hold rating to a buy rating in a research report report published on Friday.

Several other equities analysts have also weighed in on the stock. Royal Bank of Canada lowered shares of Ventas from an outperform rating to a sector perform rating and set a $59.00 price objective for the company. in a research report on Friday, November 2nd. JPMorgan Chase & Co. began coverage on shares of Ventas in a research report on Tuesday, October 30th. They set a neutral rating and a $60.00 price objective for the company. Stifel Nicolaus set a $55.00 price objective on shares of Ventas and gave the company a hold rating in a research report on Monday, October 29th. SunTrust Banks restated a hold rating and set a $58.00 price objective on shares of Ventas in a research report on Tuesday, July 31st. Finally, Cantor Fitzgerald restated a hold rating and set a $56.00 price objective on shares of Ventas in a research report on Friday, July 27th. Four equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company’s stock. Ventas has an average rating of Hold and an average target price of $55.46.

Shares of VTR opened at $61.39 on Friday. The stock has a market capitalization of $21.88 billion, a P/E ratio of 14.76, a P/E/G ratio of 4.55 and a beta of -0.02. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.56 and a quick ratio of 0.56. Ventas has a 52-week low of $46.55 and a 52-week high of $64.96.

Ventas (NYSE:VTR) last announced its earnings results on Friday, October 26th. The real estate investment trust reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The firm had revenue of $936.54 million during the quarter, compared to analyst estimates of $920.19 million. Ventas had a net margin of 19.90% and a return on equity of 4.56%. Ventas’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.71 EPS. Equities research analysts expect that Ventas will post 4.05 EPS for the current fiscal year.

In other Ventas news, EVP T Richard Riney sold 13,708 shares of the firm’s stock in a transaction dated Friday, August 31st. The shares were sold at an average price of $60.00, for a total value of $822,480.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.40% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. Columbia Asset Management acquired a new position in shares of Ventas in the third quarter worth about $111,000. Howe & Rusling Inc. boosted its holdings in shares of Ventas by 591.7% in the second quarter. Howe & Rusling Inc. now owns 2,338 shares of the real estate investment trust’s stock worth $133,000 after buying an additional 2,000 shares during the period. Girard Partners LTD. acquired a new position in shares of Ventas in the third quarter worth about $161,000. Steward Partners Investment Advisory LLC boosted its holdings in shares of Ventas by 354.7% in the second quarter. Steward Partners Investment Advisory LLC now owns 3,001 shares of the real estate investment trust’s stock worth $171,000 after buying an additional 2,341 shares during the period. Finally, Signaturefd LLC boosted its holdings in shares of Ventas by 83.9% in the second quarter. Signaturefd LLC now owns 3,043 shares of the real estate investment trust’s stock worth $173,000 after buying an additional 1,388 shares during the period. Institutional investors own 84.21% of the company’s stock.

About Ventas

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.

Featured Article: Trading Penny Stocks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply